SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Recurrent Low-Grade Carcinoma Of The Ovary Less Responsive To Chemo Than More Common Ovarian Cancers, University of Texas Study
March 10, 2008
 · 
1 min read
Lone Star Bio
Arsenic Aids Tumor Imaging When Joined To Cancer-homing Drug, University of Texas Southwestern Medical Center Researchers Find
March 5, 2008
 · 
1 min read
Lone Star Bio
Lead Exposure May Lead To Adult-Onset Obesity In Men, University of Houston Study
March 4, 2008
 · 
1 min read
Lone Star Bio
Predictors For Sickle-cell-anemia Complications, University of Texas Southwestern Medical Center Study
March 3, 2008
 · 
1 min read
Lone Star Bio
Nanomedicine System Engineered to Enhance Therapeutic Effects of Injectable Drugs
March 3, 2008
 · 
1 min read
Lone Star Bio
Arsenic Aids Tumor Imaging When Joined To Cancer-Homing Drug, University of Texas Southwestern Medical Center Researchers Find
March 3, 2008
 · 
1 min read
Lone Star Bio
M. D. Anderson Cancer Center Researchers Identify And Shut Down Protein That Fuels Ovarian Cancer
February 27, 2008
 · 
1 min read
Lone Star Bio
Cancer Research: Biochemists Solve Structure Of TGF-beta And Its Receptor, University of Texas Health Science Center Study
February 27, 2008
 · 
1 min read
Lone Star Bio
Prenatal Exposure To Lead Linked To Obesity In Males
February 22, 2008
 · 
1 min read
Lone Star Bio
Oral Contraceptives Could Work For Dogs, Cats, Pigs, Maybe Even Deer And Coyotes
February 20, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
 · 
11 min read
Press Releases
Vizient Forecasts 20% Growth in Outpatient Care, 7% in Inpatient Care
June 30, 2026
 · 
3 min read
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Load More